Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

1.74USD
11 Dec 2017
Change (% chg)

$-0.05 (-2.79%)
Prev Close
$1.79
Open
$1.78
Day's High
$1.78
Day's Low
$1.73
Volume
10,680
Avg. Vol
145,429
52-wk High
$5.50
52-wk Low
$1.08

Select another date:

Thu, Nov 9 2017

BRIEF-Catabasis Pharmaceuticals reports third quarter financial results

* Catabasis Pharmaceuticals reports third quarter 2017 financial results and reviews business progress

BRIEF-Catabasis Pharmaceuticals reports positive results from phase 2 trial of medicine for progressive muscle degeneration disease

* Catabasis Pharmaceuticals reports positive results from open-label extension of phase 2 movedmd® trial evaluating Edasalonexent in duchenne muscular dystrophy and plans to initiate phase 3 clinical trial in first half 2018

BRIEF-Catabasis Pharmaceuticals Q2 loss per share $0.32

* Catabasis Pharmaceuticals reports second quarter 2017 financial results and reviews business progress

Select another date: